SCHEMBL9780278

SCHEMBL9780278

COC(=O)CCC(=O)c1ccc(SC)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HAO1 Q9UJM8 1/20 0.51
PLK1 P53350 1/20 0.49
KMT2A Q03164 4/20 0.46
ALDH1A1 P00352 3/20 0.46
MAPT P10636 3/20 0.46
HTT P42858 2/20 0.46
LMNA P02545 2/20 0.46
HSD17B10 Q99714 1/20 0.46
MMP1 P03956 1/20 0.45
TSHR P16473 2/20 0.45
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
GAA P10253 2/20 0.42
MMP2 P08253 1/20 0.42
MMP9 P14780 1/20 0.42
MMP8 P22894 1/20 0.42
ALOX15 P16050 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MEN1 O00255 2/20 0.42
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6138736 0.86 HAO1 (0.56) HAO1PLK1TSHRMMP2MMP9
SCHEMBL17295068 0.86 HAO1 (0.58) HAO1PLK1KMT2AALDH1A1MAPT
SCHEMBL5768900 0.86 HAO1 (0.58) HAO1PLK1KMT2AALDH1A1MAPT
SCHEMBL8535748 0.80 KMT2A (0.63) KMT2AALDH1A1MAPTHTTLMNA
SCHEMBL7575160 0.80 NR4A2 (0.59) HAO1PLK1KMT2AALDH1A1MAPT
SCHEMBL2305014 0.80 HSD17B3 (0.60) KMT2AALDH1A1MAPTHTTLMNA
SCHEMBL461531 0.80 HAO1 (0.51) HAO1PLK1KMT2AALDH1A1MAPT
SCHEMBL5717808 0.80 KMT2A (0.63) HAO1PLK1KMT2AALDH1A1LMNA
SCHEMBL27197688 0.80 HAO1 (0.42) HAO1PLK1KMT2AALDH1A1MAPT
SCHEMBL10691601 0.80 ALDH1A1 (0.43) KMT2AALDH1A1MAPTHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4990526-A Skin disorders, antiallergens, antiinflammatory agents MERCK FROSST CANADA, INC. (CA) 1991-02-05 US disclosed
EP-0206741-A2 Leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1986-12-30 EP disclosed